Deep phenotyping and spatial immune contexture characterization through a combined multiplex immunofluorescence ( mIF ) approach
Literature
Read More
NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors
Press Release
Read More
Lite Paper: Real-World PD-L1 Testing Data Provides Insight into the Evolving Immuno-oncology Landscape
Blog
Read More
A single-tube NGS assay for simultaneous detection of DNA and RNA biomarkers as a comprehensive solution for clinical management and guiding therapeutic intervention of Ph-like ALL patients
Literature
Read More
Case Study: How Pharma Uses NeoGenomics Real-World Oncology Data to Accelerate Biomarker Adoption and Commercial Launch
Blog
Read More
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch
Press Release
Read More